Adding Alpha to Portfolios
While I am traveling, I wanted to CHERRY PICK a few charts from my day job: Fusion IQ:
AMGN had a buy signal on 6/23/2008
DNA had a buy signal on 7/1/2008
Not all buy and sell signals are going to give you returns like this; however they will give you an added “head’s up” that something underlying in the name has changed. And there is a stop if the name goes to a neutral.
These signals, used with FUSION IQ’s rankings, can add serious alpha to your portfolio.
70+ add and rising, add to longs…
40- and falling, sell or avoid…
Individuals can subscribe at the Fusion IQ site; Institutions looking for more information should contact Peter Greene at pgreene-at-fusioninvest-dot-com
Advertisement over.
Thursday, July 31, 2008 | 11:30 AM | Permalink
| Comments (24)
| TrackBack (0)
add to de.li.cious | 
digg this! | 
add to technorati | 
email this post
TrackBack
TrackBack URL for this entry:
https://www.typepad.com/services/trackback/6a00d8341c52a953ef00e553c432978833
Listed below are links to weblogs that reference Adding Alpha to Portfolios:
Comments
Amgen and Genentech are major biotech companies, they are mostly dependent on FDA decisions. I am wondering how can any TA predict behavior of these stocks. Amgen got some good news from the FDA concerning their anemia drugs (not too bad changes in labels); Roche offers to buy the remaining stake in Genentech and take it private. Unless these things leaked, I cannot see how could the market/TA predict these events.
Final remark – AMGN’s fate mostly depends on Denosumab (osteoporosis drug, potential blockbuster), if it gets approved – to the Moon baby, if not, well … I wish I would have a crystal ball/TA to predict this FDA decision.
Posted by: madcow | Jul 31, 2008 12:02:00 PM
The comments to this entry are closed.
